CNC
GSK icon

Canandaigua National Corp’s GSK GSK Stock Holding History

Canandaigua National Corp’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$329K Buy
+5,962
New +$323K 0.03% 270
2020
Q4 		– Sell
-5,126
Closed -$241K – 264
2020
Q3 		$241K Sell
5,126
-1,341
-21% -$67.2K 0.04% 227
2020
Q2 		$330K Buy
+6,467
New +$332K 0.06% 193

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Canandaigua National Corp's GSK Position: Q1 2026 in Review

Canandaigua National Corp opened a new position in GSK (GSK) in Q1 2026: 5,962 shares worth $329K. The stake represents 0.03% of the portfolio and ranks #270 among its holdings. This is a return to the name: Canandaigua National Corp previously reported a position in GSK as recently as Q3 2020.

Canandaigua National Corp first reported a position in GSK in Q2 2020 and has held it in 3 quarters since. The position peaked at $330K in Q2 2020. 1,034 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Canandaigua National Corp held 5,962 shares of GSK worth $329K as of Q1 2026.
  • GSK was a new Canandaigua National Corp position in Q1 2026.
  • GSK made up 0.03% of Canandaigua National Corp's portfolio in Q1 2026, its #270 holding.
  • Canandaigua National Corp first reported a position in GSK in Q2 2020 and has held it in 3 quarters since.
  • Canandaigua National Corp's GSK position peaked at $330K in Q2 2020.
  • 1,034 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Canandaigua National Corp's 13F filing for Q1 2026, filed 8 Apr 2026.